(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GIGA-564

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

GIGA-564

ST13

US500000098282853

Class

5

Filing

98282853

Registration

7995835

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

10/28/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

11/22/2023

Registration date

10/21/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/21/2025

Last transaction

10/28/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/08/2024

First use in commerce

05/08/2024

Drawing code

4

Owner type

03

Owner location

San Carlos, CA

Examiner

TORRES,MIGUEL A

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

GigaGen, Inc.

Representatives

Jessica L. Rothstein Goodwin Procter LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and therapeutic preparations for the treatment of oncological diseases and disordersinfectious diseasesimmune deficienciesautoimmune diseases; therapeutic antibodies for the treatment of oncological diseases and disordersinfectious diseasesimmune deficienciesautoimmune diseases

Publications

History of USPTO decisions and trademark events.

24 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/27/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/27/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/27/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/27/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/27/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/21/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/21/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/01/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/01/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/30/2025

IUAF

USE AMENDMENT FILED

06/02/2025

EISU

TEAS STATEMENT OF USE RECEIVED

06/02/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/28/2025

EX1G

SOU EXTENSION 1 GRANTED

03/27/2025

EXT1

SOU EXTENSION 1 FILED

03/27/2025

EEXT

SOU TEAS EXTENSION RECEIVED

03/27/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/01/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/06/2024

PUBO

PUBLISHED FOR OPPOSITION

08/06/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/27/2024

DOCK

ASSIGNED TO EXAMINER

06/25/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/16/2024

NWAP

NEW APPLICATION ENTERED

11/25/2023

Continuous trademark protection

Get notified about every new filing that threatens GIGA-564 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.